[A neurophysiologic analysis of the central effect of the new n-cholinolytic drug IEM-506].
D000679:Amygdala / Q000187:drug effects; D000818:Animals; D001692:Biological Transport; D001812:Blood-Brain Barrier; D001921:Brain / Q000187:drug effects*; D001923:Brain Chemistry / Q000187:drug effects; D002421:Caudate Nucleus / Q000187:drug effects; D002540:Cerebral Cortex / Q000187:drug effects; D004158:Diphenylacetic Acids / Q000378:metabolism / Q000494:pharmacology*; D004569:Electroencephalography; D005021:Ethylamines / Q000494:pharmacology*; D006624:Hippocampus / Q000187:drug effects; D008636:Mesencephalon / Q000187:drug effects; D009538:Nicotine / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D011817:Rabbits; D012154:Reticular Formation / Q000187:drug effects; D013565:Sympatholytics / Q000378:metabolism / Q000494:pharmacology*
D004158:Diphenylacetic Acids; D005021:Ethylamines; D013565:Sympatholytics; C002675:ethyldiphacil; D009538:Nicotine
Neĭrofiziologicheskiĭ analiz tsentral'nogo deĭstviia novogo n-kholinolitika preparata IEM-506.